Showing results (1851-1860 of 2,096) with videos related to

Sort By:
Pageof 210
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)Michael P Clark, Kelly M George, Roger G Bookland, et al.
Clinical Biochemistry|December 10, 2013
Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest painLouise Cullen, Sally Aldous, Martin Than, et al.
Clinical Chemistry|May 16, 2018
Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational StudyMartin P Than, Sally J Aldous, Richard W Troughton, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 19, 2025
Terahertz Electronic and Spin Currents in Wafer-Scale Van der Waals Bi2Se3/WSe2 Heterostructures and PolymorphsM Mičica, A Wright, S Massabeau, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 1, 2025
Exploring Practices for Implementing Smoking Cessation in Oncology Settings: A Rapid Systematic Review UpdateIsabella R DeVuono, Stephanie Posa, Naomy M C Lafond, et al.
Respirology (Carlton, Vic.)|December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progressionCarmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2015
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitorsMichael Friedman, Kristine E Frank, Ana Aguirre, et al.
Pulmonary Circulation|April 28, 2017
Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapyNura A Mohamed, Robert P Davies, Paul D Lickiss, et al.
Circulation Research|December 17, 2013
Evidence for the involvement of type I interferon in pulmonary arterial hypertensionPeter M George, Eduardo Oliver, Peter Dorfmuller, et al.
Pageof 210